论文部分内容阅读
目的观察三联活菌联合复方胃蛋白酶散治疗小儿肺炎继发性腹泻的临床疗效。方法回顾性分析方城县人民医院2009年10月至2011年10月期间184例小儿肺炎继发性腹泻患儿的临床资料,随机分为观察组和对照组,两组均给予抗生素及对症治疗,对照组在上述基础上给予复方胃蛋白酶治疗;观察组给予三联活菌联合复方胃蛋白酶散治疗,评价治疗后临床疗效。结果与对照组相比,观察组患儿住院时间、总有效率比较差异均有统计学意义(P<0.05)。结论三联活菌联合复方胃蛋白酶散治疗小儿肺炎继发性腹泻具有疗效好、病程短及不良反应少等优点。
Objective To observe the clinical efficacy of triple live bacteria combined with compound pepsin powder in treating secondary diarrhea in children with pneumonia. Methods The clinical data of 184 children with secondary pneumonia secondary to pneumonia in Fangcheng County People’s Hospital from October 2009 to October 2011 were retrospectively analyzed and randomly divided into observation group and control group. Antibiotics and symptomatic treatment were given in both groups , The control group on the basis of the compound pepsin treatment; observation group was given triple viable bacteria combined pepsin powder treatment, evaluation of clinical efficacy after treatment. Results Compared with the control group, the hospitalization time and the total effective rate in the observation group were significantly different (P <0.05). Conclusions The triple live bacteria combined with compound pepsin powder treatment of children with secondary pneumonia secondary diarrhea with good efficacy, short course and fewer adverse reactions.